A DOUBLE-BLIND COMPARATIVE TRIAL OF DIHYDROXYDIBUTYLETHER IN PATIENTS WITH CHOLESTEROL GALLSTONESSAMA C; PETRONELLI M; MASTROROBERTO G et al.1983; INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY, THERAPY AND TOXICOLOGY (1980); ISSN 506508; DEU; DA. 1983; VOL. 21; NO 2; PP. 95-97; BIBL. 16 REF.Article

Prevalence of serum IgG antibodies to hepatitis A virus in Italian haemophiliacsSCARAGGI, F. A; PERRICCI, A; PETRONELLI, M et al.Lancet (British edition). 1992, Vol 339, Num 8807, pp 1486-1487, issn 0140-6736Article

Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor : advantages of administration by continuous infusion over bolus intermittent injectionsSCARAGGI, F. A; DE MITRIO, V; MARINO, R et al.Blood coagulation & fibrinolysis. 1999, Vol 10, Num 1, pp 33-38, issn 0957-5235Article

Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in menDE PERGOLA, G; DE MITRIO, V; SCIARAFFIA, M et al.Metabolism, clinical and experimental. 1997, Vol 46, Num 11, pp 1287-1293, issn 0026-0495Article

Influence of factor VIII/Von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutationDE MITRIO, V; MARINO, R; SCARAGGI, F. A et al.Blood coagulation & fibrinolysis. 1999, Vol 10, Num 7, pp 409-416, issn 0957-5235Article